These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27032308)
1. [Augmented renal clearance of antibiotics may lead to inadequate dosings for patients with sepsis]. Moser C; Hartvig T; Schierbeck J; Høiby N Ugeskr Laeger; 2016 Mar; 178(11):V05150426. PubMed ID: 27032308 [TBL] [Abstract][Full Text] [Related]
2. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock. Landersdorfer CB; Nation RL Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163 [TBL] [Abstract][Full Text] [Related]
3. Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization. Sime FB; Udy AA; Roberts JA Curr Opin Pharmacol; 2015 Oct; 24():1-6. PubMed ID: 26119486 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic therapy in sepsis: No next time for a second chance! Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622 [TBL] [Abstract][Full Text] [Related]
5. Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients? Dhont E; Van Der Heggen T; De Jaeger A; Vande Walle J; De Paepe P; De Cock PA Pediatr Nephrol; 2020 Jan; 35(1):25-39. PubMed ID: 30374606 [TBL] [Abstract][Full Text] [Related]
6. Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial. Udy AA; Dulhunty JM; Roberts JA; Davis JS; Webb SAR; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Paul SK; Lipman J; ; Int J Antimicrob Agents; 2017 May; 49(5):624-630. PubMed ID: 28286115 [TBL] [Abstract][Full Text] [Related]
7. Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients. Akers KS; Niece KL; Chung KK; Cannon JW; Cota JM; Murray CK J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S163-70. PubMed ID: 24770557 [TBL] [Abstract][Full Text] [Related]
8. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study. Carrié C; Petit L; d'Houdain N; Sauvage N; Cottenceau V; Lafitte M; Foumenteze C; Hisz Q; Menu D; Legeron R; Breilh D; Sztark F Int J Antimicrob Agents; 2018 Mar; 51(3):443-449. PubMed ID: 29180280 [TBL] [Abstract][Full Text] [Related]
9. Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics. Hobbs AL; Shea KM; Roberts KM; Daley MJ Pharmacotherapy; 2015 Nov; 35(11):1063-75. PubMed ID: 26598098 [TBL] [Abstract][Full Text] [Related]
10. Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study. Huttner A; Von Dach E; Renzoni A; Huttner BD; Affaticati M; Pagani L; Daali Y; Pugin J; Karmime A; Fathi M; Lew D; Harbarth S Int J Antimicrob Agents; 2015 Apr; 45(4):385-92. PubMed ID: 25656151 [TBL] [Abstract][Full Text] [Related]
11. Augmented renal clearance: implications for antibacterial dosing in the critically ill. Udy AA; Roberts JA; Boots RJ; Paterson DL; Lipman J Clin Pharmacokinet; 2010; 49(1):1-16. PubMed ID: 20000886 [TBL] [Abstract][Full Text] [Related]
16. The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose. Tamatsukuri T; Ohbayashi M; Kohyama N; Kobayashi Y; Yamamoto T; Fukuda K; Nakamura S; Miyake Y; Dohi K; Kogo M J Infect Chemother; 2018 Oct; 24(10):834-840. PubMed ID: 30087007 [TBL] [Abstract][Full Text] [Related]
17. Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance? Udy AA; Lipman J; Jarrett P; Klein K; Wallis SC; Patel K; Kirkpatrick CM; Kruger PS; Paterson DL; Roberts MS; Roberts JA Crit Care; 2015 Jan; 19(1):28. PubMed ID: 25632974 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic therapy as personalized medicine - general considerations and complicating factors. Moser C; Lerche CJ; Thomsen K; Hartvig T; Schierbeck J; Jensen PØ; Ciofu O; Høiby N APMIS; 2019 May; 127(5):361-371. PubMed ID: 30983040 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic dose optimization in critically ill patients. Cotta MO; Roberts JA; Lipman J Med Intensiva; 2015 Dec; 39(9):563-72. PubMed ID: 26415688 [TBL] [Abstract][Full Text] [Related]
20. The relevance of drug clearance to antibiotic dosing in critically ill patients. Roberts DM Curr Pharm Biotechnol; 2011 Dec; 12(12):2002-14. PubMed ID: 21554217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]